BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9730300)

  • 1. Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients.
    Barzilai A; Rubinovich B; Blank-Porat D; Rubinstein E; Keller N; Levi I
    Scand J Infect Dis; 1998; 30(2):143-6. PubMed ID: 9730300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Mycobacterium simiae infection in patients with AIDS.
    Al-Abdely HM; Revankar SG; Graybill JR
    J Infect; 2000 Sep; 41(2):143-7. PubMed ID: 11023758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
    Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
    Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated Mycobacterium simiae infection in a patient with adult-onset immunodeficiency due to anti-interferon-gamma antibodies - a case report.
    Keragala BSDP; Gunasekera CN; Yesudian PD; Guruge C; Dissanayaka BS; Liyanagama DP; Jinadasa GIM; Constantine SR; Herath HMMTB
    BMC Infect Dis; 2020 Apr; 20(1):258. PubMed ID: 32234012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of drug regimens and treatment outcome in patients with
    Dashtbin S; Mirkalantari S; Dadashi M; Darban-Sarokhalil D
    Expert Rev Anti Infect Ther; 2022 Jul; 20(7):1015-1023. PubMed ID: 35306950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image of the month: Disseminated Nontuberculous Mycobacteriosis.
    Hasegawa T; Yuya T; Yoshimura Y; Amano Y; Sakamoto Y; Tachikawa N
    Am J Gastroenterol; 2015 Dec; 110(12):1654. PubMed ID: 26673493
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.
    Shafran SD; Mashinter LD; Phillips P; Lalonde RG; Gill MJ; Walmsley SL; Toma E; Conway B; Fong IW; Rachlis AR; Williams KE; Garber GE; Schlech WF; Smaill F; Pradier C
    Ann Intern Med; 2002 Nov; 137(9):734-7. PubMed ID: 12416943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.
    Coolen-Allou N; Touron T; Belmonte O; Gazaille V; Andre M; Allyn J; Picot S; Payet A; Veziris N
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760130
    [No Abstract]   [Full Text] [Related]  

  • 10. A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements.
    Burman WJ; Reves RR; Rietmeijer CA; Cohn DL
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):163-9. PubMed ID: 9441082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study.
    Johnson RC; Ifebe D; Hans-Moevi A; Kestens L; Houessou R; Guédénon A; Meyers WM; Portaels F
    AIDS; 2002 Aug; 16(12):1704-5. PubMed ID: 12172103
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
    Marras TK; Morris A; Gonzalez LC; Daley CL
    Am J Respir Crit Care Med; 2004 Oct; 170(7):793-8. PubMed ID: 15215152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.
    Kemper CA; Meng TC; Nussbaum J; Chiu J; Feigal DF; Bartok AE; Leedom JM; Tilles JG; Deresinski SC; McCutchan JA
    Ann Intern Med; 1992 Mar; 116(6):466-72. PubMed ID: 1739237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
    Dubé MP; Torriani FJ; See D; Havlir DV; Kemper CA; Leedom JM; Tilles JG; McCutchan JA; Sattler FR
    Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
    Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
    Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive disseminated histoplasmosis with concomitant disseminated nontuberculous mycobacterial infection in a patient with AIDS from a nonendemic region (California).
    Choi J; Nikoomanesh K; Uppal J; Wang S
    BMC Pulm Med; 2019 Feb; 19(1):46. PubMed ID: 30791902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. About two cases of Mycobacterium simiae infection in AIDS: review of the pathogenicity.
    Vandercam B; Gala JL; Gerain J; Degraux J; Bourlond A; Colebunders B; Pirard C; Portaels F
    Acta Clin Belg; 1998 Jun; 53(3):206-12. PubMed ID: 9701858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium europaeum lung disease in an immunocompetent patient without underlying lung disease.
    Fujiwara K; Furuuchi K; Aono A; Uesugi F; Osawa T; Shimoda M; Takaki A; Kurashima A; Ohta K; Mitarai S; Morimoto K
    J Infect Chemother; 2021 Jan; 27(1):107-109. PubMed ID: 32988729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
    Parenti DM; Williams PL; Hafner R; Jacobs MR; Hojczyk P; Hooton TM; Barber TW; Simpson G; van der Horst C; Currier J; Powderly WG; Limjoco M; Ellner JJ
    AIDS; 1998 Dec; 12(18):2439-46. PubMed ID: 9875582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome.
    Butt AA
    Am J Med Sci; 1998 Jan; 315(1):50-5. PubMed ID: 9427575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.